Category: Covid-19

Page 609«..1020..608609610611..620630..»

GOP Said To Require A Negative Covid-19 Test To Attend Spring Donor Event In Florida – Forbes

April 7, 2021

More From ForbesMonster Energy And Idol Roc Collaborate On Events To Build Community With Artists And Fans.","scope":{"topStory":{"title":"Monster Energy And Idol Roc Collaborate On Events To Build Community With Artists And Fans.","uri":"https://www.forbes.com/sites/ericfuller/2021/04/06/monster-energy-and-idol-roc-collaborate-on-events-to-build-community-with-artists-and-fans/","date":{"monthDayYear":"Apr 6, 2021","hourMinute":"08:57","amPm":"pm","isEDT":true},"index":1}},"id":"c6ckj64bp2l400"},{"textContent":"

Apr 6, 2021,08:03pm EDT

Apr 6, 2021,07:49pm EDT

Apr 6, 2021,07:30pm EDT

Apr 6, 2021,07:25pm EDT

Apr 6, 2021,06:53pm EDT

Apr 6, 2021,06:45pm EDT

Continue reading here:

GOP Said To Require A Negative Covid-19 Test To Attend Spring Donor Event In Florida - Forbes

DHEC: S.C. sees over 100 COVID-19 breakthrough cases in fully vaccinated people – WMBF

April 7, 2021

A breakthrough case is defined as a resident testing positive for COVID-19 more than 14 days after completing the primary series of a Food and Drug Administration-authorized vaccine, in the absence of a positive coronavirus test in the 45 days prior to the current positive test, according to DHEC and the S.C. Health Alert Network.

Read the original here:

DHEC: S.C. sees over 100 COVID-19 breakthrough cases in fully vaccinated people - WMBF

How Long Will COVID-19 Vaccine Protection Last? Heres What Doctors Know So Far – Prevention.com

April 7, 2021

More than 63 million people have been fully vaccinated against COVID-19an exciting step toward ending the pandemic after more than a year of lockdowns and mask wearing. Recently, the U.S. hit a new record by administering more than 4 million doses in 24 hours. President Joe Biden also confirmed that a majority of U.S. adults will be eligible for the vaccine by April 19, well before his initial May 1 deadline.

Clinical trials have shown that the the authorized coronavirus vaccines are safe and highly effective at preventing severe forms of COVID-19. But theres still one question that researchers are in the process of answering: How long does vaccine protection actually last? And will follow-up doses be necessary to extend immunity and ward off new, more infectious variants of the virus?

Data continues to evolve, but it looks promising. Heres what experts know so far.

On April 1, Pfizer announced that its COVID-19 vaccine offers up to six months of strong protection against symptomatic COVID-19. Specifically, data from its phase 3 study showed that the vaccine was 91.3% effective at preventing COVID-19 for up to six months after the second dose and 100% effective against severe disease as defined by the CDC.

At this point, six months is the time frame for which they have secure information, explains William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine.

But that doesnt mean that the vaccine is only good for six months. Its possible that the Pfizer vaccine, and others like it, will provide immunity for longer than that, says infectious disease expert Amesh A. Adalja, M.D., senior scholar at the Johns Hopkins Center for Health Security. He bases his prediction from what we know about the flu vaccine, which is good for at least a year.

As for Modernas and Johnson & Johnsons respective vaccines, those were authorized by the Food and Drug Administration after the Pfizer vaccine, so theres currently less data on their long-term efficacy.

However, Richard Watkins, M.D., an infectious disease specialist and professor of internal medicine at the Northeast Ohio Medical University, believes Modernas vaccine will provide protection for a similar period of time as Pfizers vaccine, since it has the same mechanism of action. (Both the Pfizer and Moderna vaccines use mRNA technology.)

The Johnson & Johnson vaccine uses a different mechanismits a traditional adenovirus vaccine, like the flu vaccinebut it should also offer similar protection, notes Dr. Schaffner. Why? The outcomeantibodies to SARS-CoV-2is the same with both types of vaccines, he says.

Its not entirely clear right now, but Dr. Schaffner says it wont be like an on and off switch. If protection from the vaccine wears off, it will fade slowly, he says. Because every persons immune system is slightly different, it may happen at a different pace for each individual.

The good news is, doctors believe that if vaccinated people end up contracting COVID-19 down the road, their symptoms will certainly be less severe. There should be some residual protection for quite some time, Dr. Schaffner says. It goes back to the gradual decrease in protection. Basically, its expected that your immune system will at least remember that its seen something that looks like this coronavirus before and then go to work.

A small study published in January found that 95% of people who contracted COVID-19 still had antibodies to the virus up to eight months after they were infectedand experts predict that protection from the vaccine will last longer than natural immunity (a.k.a. becoming ill with COVID-19 and recovering). Not only that, Dr. Schaffner believes protection from the vaccine will likely be more complete and offer more protection against variants than natural immunity. More research is needed to prove that theory, though.

Currently, both Pfizer and Moderna are studying whether a booster shot may be helpful in maintaining COVID-19 protection following initial vaccination, especially when it comes to newly-emerging variants.

Its too early to determine whether or not booster doses may be needed and what the interval may be, Dr. Adalja says, but theres a good chance follow-up shots will be necessary, especially since there is a rare but real chance of having a breakthrough infection. This occurs when someone who is fully immunized against the virus still ends up being infected by it.

These vaccines that were using are fabulous but theyre not perfect, Dr. Schaffner says. While they are incredibly effective at preventing serious disease, there is still a slim chance for a minor COVID-19 illness to occur after vaccination.

I would think we would need boostering at some point, whether its annually or every two or five years, says Dr. Schaffner. This virus will likely be with us for a long time, the way influenza is, and there will be variants and mutations that would require a booster to target them.

This article is accurate as of press time. However, as the COVID-19 pandemic rapidly evolves and the scientific communitys understanding of the novel coronavirus develops, some of the information may have changed since it was last updated. While we aim to keep all of our stories up to date, please visit online resources provided by the CDC, WHO, and your local public health department to stay informed on the latest news. Always talk to your doctor for professional medical advice.

Go here to join Prevention Premium (our best value, all-access plan), subscribe to the magazine, or get digital-only access.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Read more:

How Long Will COVID-19 Vaccine Protection Last? Heres What Doctors Know So Far - Prevention.com

China reports biggest daily COVID-19 case jump in over 2 months – Reuters

April 7, 2021

(Reuters) -China reported its biggest daily jump in new COVID-19 cases in more than two months, as a city on the border with Myanmar in southwestern Yunnan province accounted for all new local cases.

FILE PHOTO: People wearing face masks walk on a street market, following an outbreak of the coronavirus disease (COVID-19) in Wuhan, Hubei province, China February 8, 2021. REUTERS/Aly Song

Ruilis local government put residents in its urban area under home quarantine, launched a massive testing drive and began restricting people from leaving and entering the city from last week after reporting COVID-19 patients.

The city accounted for all of the 15 new local cases reported on April 4. The total number of new COVID-19 infections, including imported infections originating from overseas, stood at 32, marking the highest total since Jan. 31.

Genetic analysis of the cases discovered in Ruili suggest the new local infections stem from viruses imported from Myanmar, state media reported. Of the new patients reported in the city, 11 of them were identified as Myanmar citizens.

Ruili is a key transit point for Yunnan province, which has struggled to monitor its rugged 4,000 km (2,500-mile) border with Laos, Myanmar and Vietnam for illegal immigration amid a wave of unauthorised crossings last year by people seeking a haven from the pandemic.

On Monday evening, city authorities announced three high risk and six medium risk areas in Ruili as of 7pm local time (1100 GMT), reported state broadcaster CCTV.

CCTV also reported that Ruili would conduct a second testing drive round from April 6 onwards, and that residents who had visited Jiegaoyu City, a jade market in one of the high risk areas, between March 15 and 29 would need to be quarantined at home.

Local authorities have also began a vaccination drive in Ruili in a bid to contain COVID-19 and build up herd immunity in the city.

The number of new asymptomatic cases, which China does not classify as confirmed cases, stood at 18, matching the total from a day earlier.

The total number of confirmed COVID-19 cases in mainland China now stands at 90,305, while the death toll remains unchanged at 4,636.

Reporting by Se Young Lee in Washington; Emily Chow and Wang Jing in Shanghai; Editing by Himani Sarkar, Michael Perry, Kirsten Donovan

Excerpt from:

China reports biggest daily COVID-19 case jump in over 2 months - Reuters

DHEC Epidemiologist: Another COVID-19 surge in SC is a top concern – WIS10

April 7, 2021

According to TSA, more than 1.5 million people flew over the holiday weekend, roads were congested at times, and people across the state gathered to celebrate the Easter holiday. And with temperatures on the rise, more businesses opening, and people continuing to go on spring vacations, she said the more contagious variants of the virus could cause a surge in cases.

Read more:

DHEC Epidemiologist: Another COVID-19 surge in SC is a top concern - WIS10

Verify: Does CVS have a waitlist to get the COVID-19 vaccine? – ABC10.com KXTV

April 7, 2021

Here is what you need to do know before you schedule your appointment at CVS to get the COVID-19 vaccine.

SACRAMENTO, Calif. As more people are becoming eligible for the COVID-19 vaccine, people are wondering if they can sign up for unused dosages at their local CVS.

Many CVS locations will soon have the COVID-19 vaccine available for all people 16 and older in California. Here is what you need to know before you rush to your nearest CVS.

CVS offers those who want the vaccine the ability to schedule an appointment through its websiteand its phone app. They have not provided a phone number to call to make an appointment.

People are discouraged from showing up for drop-in appointments because CVS does not have a waitlist for unused doses.

According to its website, CVS is currently vaccinating those who are 50 and older and those older than 16 who have a medical condition that would increase the risk of severe COVID-19 symptoms. Health care workers, food and agriculture workers, educational workers are also some of the eligible groups for the treatment.

For more information regarding those who qualify for the vaccine at CVS, click here.

More here:

Verify: Does CVS have a waitlist to get the COVID-19 vaccine? - ABC10.com KXTV

Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials – Reuters

April 7, 2021

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Novavax logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) - Novavax Inc said on Monday participants in its ongoing COVID-19 vaccine trials in South Africa and the UK can now receive additional shots, ensuring those who received a placebo can also get the active vaccine.

Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other authorized vaccines are available.

The company said it planned to cross over participants in its ongoing large, late-stage study in the United States and Mexico, for which the company plans to read out initial clinical data during the second quarter.

If authorized for emergency use in the United States, Novavaxs two-shot vaccine would help ramp up ongoing vaccination efforts in the country with currently authorized vaccines from Pfizer/BioNTech, Moderna Inc and Johnson & Johnson.

As part of the updated trial design, all participants of the trials in the UK and the U.S. will be offered the chance to receive an additional round of shots, the company said.

Participants who opt to do so will receive two additional doses of either vaccine for those who initially received placebo, or placebo for those who first got vaccine.

All participants will continue to be blinded or not know if they got the experimental vaccine or a placebo.

See the rest here:

Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials - Reuters

CDC awards $120.5M to Mid-South states to expand COVID-19 vaccine access and increase acceptance in minority c – WMC

April 7, 2021

We are doing everything we can to expand access to vaccinations, said CDC Director Rochelle P. Walensky. Millions of Americans are getting vaccinated every day, but we need to ensure that we are reaching those in the communities hit hardest by this pandemic. This investment will support state and local health departments and community-based organizations as they work on the frontlines to increase vaccine access, acceptance, and uptake.

More:

CDC awards $120.5M to Mid-South states to expand COVID-19 vaccine access and increase acceptance in minority c - WMC

About 50% of Berkeley residents have received at least one dose of the COVID-19 vaccine – Berkeleyside

April 7, 2021

Nearly half of Berkeley residents above 16 years old have gotten at least one dose of the COVID-19 vaccine as of Tuesday, the city announced, putting it among the cities with the highest vaccination rates in Alameda County and the state.

According to county data, 52,278 people in Berkeley (49.4%) have received at least one dose of the Pfizer-BioNTech, Moderna or Johnson & Johnson COVID-19 vaccine (which only requires one dose) and, of those, 33,400 people (or about 30% of the citys population) are fully vaccinated. About 46% of the county as a whole has received at least one dose and 29% are fully vaccinated.

Berkeley ranks sixth in Alameda County behind Piedmont (68.5% first doses) Albany (59.7%), Alameda (54.2%), Sunol (53.3%) and Castro Valley (52.9%). Apart from Albany, which also houses the Golden Gate Fields vaccination site, most of these cities have a larger share of residents who are older than 65 and had priority access to the vaccine at the beginning of the rollout.

Vaccinating our city, which is critical to saving lives and getting Berkeley back to business, remains my number one priority, Mayor Jesse Arregun said in the statement, describing efforts to prioritize COVID-19 vaccine distribution at hospitals,senior care homes, homeless sheltersand partnerships with local Black churchesand religious organizations for underserved populations.

Vaccines for Berkeley residents have come from multiple sources, including a mass vaccination site run by FEMA at the Oakland Coliseum, which is set to continue operations, sites staffed by community health organizations like LIfeLong Medical Care, primary care providers, Kaiser, UC Berkeleyand offshoot mobile clinics from the FEMA site.

The city itself has been vaccinating essential workers, teachers, food service employees and more at its own clinics throughout the city, as well as running the Golden Gate Fields mass vaccination site with Curative and Alameda County. On its dashboard, the city says it has received 56,165 doses and administered 47,103 doses to date. Thats about 90% of the total first doses for Berkeley residents.

Eligibility opened up to everyone above the age of 50 last week and everyone above the age of 16 can start booking appointments on April 15.

The state announced Tuesday that the surge of vaccine availability and vaccinations in hardest-hit counties will allow California to leave the tier system and open up all sectors on June 15. Over 30 million doses have been distributed across the state, and Alameda County is in the top five counties statewide with over a million doses administered. About 23% of the states population and 19% of the United States is fully vaccinated.

Read more:

About 50% of Berkeley residents have received at least one dose of the COVID-19 vaccine - Berkeleyside

Page 609«..1020..608609610611..620630..»